We are pleased to announce that the next call for VALIDATE pump-priming grants is now open.
The VALIDATE Network aims to accelerate vaccine research and development for complex intracellular pathogens that cause diseases significant to low and middle-income countries (LMIC), with an initial focus on Mycobacterium tuberculosis, Leishmania spp, Burkholderia pseudomallei and Mycobacterium leprae. The Network’s priorities lie in cross-pathogen, cross-discipline, cross-species and cross-continent research, with the aim of making step-change progress towards efficacious vaccines targeting these pathogens.
Grants are available for pump-primig projects of up to £50,000 via competitiva application to the Network Management Board. Projects should run for a maximum of 12 months and should lead to relevant and useful data for the field, or produce pilot data that will lead to a larger grant application to an external funder. Projects must be scientifically excellent, and fall within the VALIDATE remit. The NMB particularly encourage projects including any of the following: cross-pathogen research, cross-discipline research, projects promoting the One Health agenda, in vivo research, translational research, collaborative projects led by and/or involving LMIC researchers, new collaborations between VALIDATE members, projects led by and/or including Early Career Researchers, projects with industry involvement.
Investigators and Associates may apply for awards, as well as Affiliate members who attended the VALIDATE 2nd Annual Meeting in November 2018 and participated in the Ideas Laboratory collaborative session.
The call closes on 12 Feb 2019 - you can find out more details on the call, and how to apply here.
Published: 29 Nov 2018
